Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data

This letter highlights a rare association of anti-HER2 cancer therapy with development of pulmonary arterial hypertension, based on a review of data from the FDA https://bit.ly/2X90xDu

Detalles Bibliográficos
Autores principales: Umoru, Godsfavour, Taitano, Matthew, Beshay, Sarah, Niravath, Polly, Sahay, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369436/
https://www.ncbi.nlm.nih.gov/pubmed/32714960
http://dx.doi.org/10.1183/23120541.00199-2020
_version_ 1783560781379403776
author Umoru, Godsfavour
Taitano, Matthew
Beshay, Sarah
Niravath, Polly
Sahay, Sandeep
author_facet Umoru, Godsfavour
Taitano, Matthew
Beshay, Sarah
Niravath, Polly
Sahay, Sandeep
author_sort Umoru, Godsfavour
collection PubMed
description This letter highlights a rare association of anti-HER2 cancer therapy with development of pulmonary arterial hypertension, based on a review of data from the FDA https://bit.ly/2X90xDu
format Online
Article
Text
id pubmed-7369436
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-73694362020-07-23 Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data Umoru, Godsfavour Taitano, Matthew Beshay, Sarah Niravath, Polly Sahay, Sandeep ERJ Open Res Original Research Letters This letter highlights a rare association of anti-HER2 cancer therapy with development of pulmonary arterial hypertension, based on a review of data from the FDA https://bit.ly/2X90xDu European Respiratory Society 2020-07-20 /pmc/articles/PMC7369436/ /pubmed/32714960 http://dx.doi.org/10.1183/23120541.00199-2020 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Original Research Letters
Umoru, Godsfavour
Taitano, Matthew
Beshay, Sarah
Niravath, Polly
Sahay, Sandeep
Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data
title Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data
title_full Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data
title_fullStr Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data
title_full_unstemmed Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data
title_short Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data
title_sort pulmonary arterial hypertension in breast cancer patients on her2-targeted therapy: a review of fda adverse events reporting system data
topic Original Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369436/
https://www.ncbi.nlm.nih.gov/pubmed/32714960
http://dx.doi.org/10.1183/23120541.00199-2020
work_keys_str_mv AT umorugodsfavour pulmonaryarterialhypertensioninbreastcancerpatientsonher2targetedtherapyareviewoffdaadverseeventsreportingsystemdata
AT taitanomatthew pulmonaryarterialhypertensioninbreastcancerpatientsonher2targetedtherapyareviewoffdaadverseeventsreportingsystemdata
AT beshaysarah pulmonaryarterialhypertensioninbreastcancerpatientsonher2targetedtherapyareviewoffdaadverseeventsreportingsystemdata
AT niravathpolly pulmonaryarterialhypertensioninbreastcancerpatientsonher2targetedtherapyareviewoffdaadverseeventsreportingsystemdata
AT sahaysandeep pulmonaryarterialhypertensioninbreastcancerpatientsonher2targetedtherapyareviewoffdaadverseeventsreportingsystemdata

Ejemplares similares